NDC Product
Human Prescription DrugRybrevant Faspro NDC 57894-510
- Generic Name
- Amivantamab And Hyaluronidase-lpuj (human Recombinant)
- Dosage Form
- Injection
- Route
- Subcutaneous
- Marketing
- BLA
Active Listing
Rybrevant Faspro 3520 mg / 44000 UNT in 22 mL Injection
RxNorm 2735804 NDC Crossover
NDC Directory Crossover & Product Mapping
The following National Drug Codes (NDCs) are directly associated with the clinical concept for Rybrevant Faspro 3520 mg / 44000 UNT in 22 mL Injection (RxCUI 2735804). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.
Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.
